vorinostat has been researched along with Brain Damage, Chronic in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, T | 1 |
Zhang, YM | 1 |
Han, D | 1 |
Hua, R | 1 |
Guo, BN | 1 |
Hu, SQ | 1 |
Yan, XL | 1 |
Xu, T | 1 |
1 other study available for vorinostat and Brain Damage, Chronic
Article | Year |
---|---|
Involvement of IL-17 in Secondary Brain Injury After a Traumatic Brain Injury in Rats.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Brain Damage, Chronic; Brain Injuries, Traumatic; | 2017 |